GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biovica International AB (OSTO:BIOVIC B) » Definitions » Market Cap

Biovica International AB (OSTO:BIOVIC B) Market Cap : kr150.63 Mil (As of May. 25, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Biovica International AB Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Biovica International AB's share price for the quarter that ended in Jan. 2024 was kr2.6. Biovica International AB's Shares Outstanding (EOP) for the quarter that ended in Jan. 2024 was 84.06 Mil. Therefore, Biovica International AB's market cap for the quarter that ended in Jan. 2024 was kr218.54 Mil.

Biovica International AB's quarterly market cap declined from Jul. 2023 (kr387.43 Mil) to Oct. 2023 (kr113.67 Mil) but then increased from Oct. 2023 (kr113.67 Mil) to Jan. 2024 (kr218.54 Mil).

Biovica International AB's annual market cap declined from Apr. 2021 (kr1,150.73 Mil) to Apr. 2022 (kr905.93 Mil) and declined from Apr. 2022 (kr905.93 Mil) to Apr. 2023 (kr331.17 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Biovica International AB's Enterprise Value for Today is kr53.61 Mil.


Biovica International AB Market Cap Historical Data

The historical data trend for Biovica International AB's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biovica International AB Market Cap Chart

Biovica International AB Annual Data
Trend Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
Market Cap
Get a 7-Day Free Trial Premium Member Only 194.19 365.39 1,150.73 905.93 331.17

Biovica International AB Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 408.47 331.17 387.43 113.67 218.54

Competitive Comparison of Biovica International AB's Market Cap

For the Biotechnology subindustry, Biovica International AB's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biovica International AB's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biovica International AB's Market Cap distribution charts can be found below:

* The bar in red indicates where Biovica International AB's Market Cap falls into.



Biovica International AB Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Biovica International AB's Market Cap for the fiscal year that ended in Apr. 2023 is calculated as

Market Cap (A: Apr. 2023 )=Share Price (A: Apr. 2023 )*Shares Outstanding (EOP) (A: Apr. 2023 )
=kr7.24*45.7414
=kr331.17

Biovica International AB's Market Cap for the quarter that ended in Jan. 2024 is calculated as

Market Cap (Q: Jan. 2024 )=Share Price (Q: Jan. 2024 )*Shares Outstanding (EOP) (Q: Jan. 2024 )
=kr2.6*84.0556
=kr218.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biovica International AB  (OSTO:BIOVIC B) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Biovica International AB Market Cap Related Terms

Thank you for viewing the detailed overview of Biovica International AB's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Biovica International AB (OSTO:BIOVIC B) Business Description

Traded in Other Exchanges
Address
Dag Hammarskjolds vag 54B, Uppsala Science Park, Uppsala, SWE, 752 37
Biovica International AB is a biotech company. It develops and commercializes blood-based diagnostic tests with biomarkers that improve monitoring and evaluation of modern cancer treatments. Through collaboration with world- leading cancer institutes and pharmaceutical companies, it promotes the trend in healthcare for personalized treatment, with a primary focus on patient survival and benefits to society. DiviTum is manufactured by the company and sold as a kit consisting of a reaction plate with reagents that have been optimized for ELISA applications.

Biovica International AB (OSTO:BIOVIC B) Headlines

No Headlines